Two cases of Chronic Neutrophilic Leukemia were successfully treated with Allogeneic Stem Cell Transplantation
Authors:
Open Access
- 27 May 2022
- journal article
- research article
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 9 (6) , 375-377
Abstract
Objective: Chronic Neutrophilic Leukemia (CNL) is a rarely seen myeloproliferative neoplasia (MPN) in which the BCR-ABL1 gene mutation is negative, and is characterized by persistent neutrophilic proliferation in the bloodstream and granulocytic hyperplasia in the bone marrow. CNL is usually diagnosed incidentally in asymptomatic individuals with persistent neutrophilic leukocytosis. When genetically examined, BCR-ABL1 fusion gene, JAK-2 V617F, and exon12 mutations, CALR mutations, PDGFRA-B, FGRF1 mutations are all not detected, while CSF3R mutation is observed in most of the cases. The WHO-2016 classification determined the presence of CSF3R T618I and other activating CSF3R mutations as diagnostic criteria. While the prognosis is poor in CNL cases with the CSF3R T618I mutation, it is more moderate in the presence of other CSF3R mutations. The average life expectancy is 21-30 months, and 5-year survival rates are around 28%. Although no treatment modality provides an average survival advantage other than hematopoietic stem cell transplantation (HSCT), there is no accepted 'standard of care' consensus. HSCT procedures performed in CNL cases are limited in the literature. Case: In this study, we presented two cases of CNL who were successfully treated with allogeneic stem cell transplantation and cured.Keywords
This publication has 12 references indexed in Scilit:
- Chronic neutrophilic leukemia: a clinical perspectiveOncoTargets and Therapy, 2015
- T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell TransplantationAnnals of Laboratory Medicine, 2015
- ASXL1 mutations are frequent and prognostically detrimental in CSF3R‐mutated chronic neutrophilic leukemiaAmerican Journal of Hematology, 2015
- OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CMLNew England Journal of Medicine, 2013
- Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemiaBlood, 2012
- Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO definedBest Practice & Research Clinical Haematology, 2006
- WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literatureLeukemia, 2004
- CHRONIC NEUTROPHILIC LEUKAEMIA: A DISTINCT CLINICAL ENTITY?British Journal of Haematology, 2002
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- Successful alpha‐2b‐interferon therapy for chronic neutrophilic leukemiaAmerican Journal of Hematology, 1993